<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04322825</url>
  </required_header>
  <id_info>
    <org_study_id>H-17004467</org_study_id>
    <nct_id>NCT04322825</nct_id>
  </id_info>
  <brief_title>Mollii - Personalized Suit for Treatment of Spasticity, GFMCS 3-5</brief_title>
  <official_title>Mollii - Personalized Suit for Treatment of Spasticity, GFMCS3-5</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eurostars</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to examine the effect on spasticity and function of
      multifocal transcutaneous electrical stimulation incorporated in a 2-piece (Mollii) suit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective cohort study, the participants (children with predominantly spastic CP,
      GFMCS 3-5) wore the suit for 1 hour every second day for 24 weeks. The investigators
      evaluated level of spasticity using the modified Ashworth scale (MAS) and other related
      measures before initiation, after 4, 12, and 24 weeks. Two motor related smart goals were
      defined and evaluated by the goal attainment scale (GAS). GMFM-66 and posture and postural
      ability scale (PPAS) were performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Actual">July 1, 2019</completion_date>
  <primary_completion_date type="Actual">July 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>prospective cohort study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>modified ashworth scale</measure>
    <time_frame>24 weeks</time_frame>
    <description>spasticity evaluation from 0 (best) to 4 (worst) in modified ashworth scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Goal Attainment Scale</measure>
    <time_frame>24 weeks</time_frame>
    <description>smart goals from -2 (worst) to +2 (best)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Spastic Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 weeks of TENS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TENS incorporated into the Mollii suit</intervention_name>
    <description>trans cutaneous electric stimulation,</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - cerebral palsy with spastic disease, GMFCS 3-5.

        Exclusion Criteria:

          -  other disorders affecting the sensorimotor functions without spasticity,

          -  implanted electric medical devices,

          -  BMI&gt;35

          -  other severe concomitant diseases such as cancer, cardiovascular, inflammatory,
             psychiatric disease, medical dysregulated epilepsy or hypertension.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>hospital of Hvidovre</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>November 1, 2019</study_first_submitted>
  <study_first_submitted_qc>March 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2020</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>christian wong</investigator_full_name>
    <investigator_title>consultant, clinical lecturer, PhD</investigator_title>
  </responsible_party>
  <keyword>Mollii suit;</keyword>
  <keyword>Goal Attainment Scale;</keyword>
  <keyword>Reciprocal inhibition;</keyword>
  <keyword>modified ashworth scale,</keyword>
  <keyword>trans cutaneous electric stimulation, TENS</keyword>
  <keyword>Spasticity reduction,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>we are not permitted to share these data due to gpdr ruels</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

